The pharmaceutical industry is continuously evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To fulfill this demand, US-based manufacturing services are gaining traction. These providers offer a wide-ranging suite of solutions, fro